Deanna D Strable Soethout Principal Financial Group Inc (PFG) insider trading activity

Deanna D Strable Soethout is President and CEO of PRINCIPAL FINANCIAL GROUP INC. Currently has a direct ownership of 153,468 shares of PFG, which is worth approximately $13 Million. The most recent transaction as insider was on Dec 31, 2025, when has been sold 38,237 shares (Common Stock) at a price of $88.55 per share, resulting in proceeds of $3,385,886. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 153K

0.34% 3M change

36.59% 12M change

Total Value Held $13 Million

DEANNA D STRABLE-SOETHOUT Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 31 2025	SELL Sale (or disposition) back to the issuer	$3,385,886 $88.55 p/Share	38,237 Reduced 19.95%	153,468 Common Stock
Dec 31 2025	BUY Grant, award, or other acquisition	$1,429,299 $37.38 p/Share	38,237 Added 16.63%	191,705 Common Stock
Dec 24 2025	SELL Sale (or disposition) back to the issuer	$1,865,385 $90.05 p/Share	20,715 Reduced 11.89%	153,468 Common Stock
Dec 24 2025	BUY Grant, award, or other acquisition	$774,326 $37.38 p/Share	20,715 Added 10.63%	174,183 Common Stock
Dec 23 2025	SELL Sale (or disposition) back to the issuer	$18,000 $90.0 p/Share	200 Reduced 0.13%	153,468 Common Stock
Dec 23 2025	BUY Grant, award, or other acquisition	$7,476 $37.38 p/Share	200 Added 0.13%	153,668 Common Stock
Dec 19 2025	SELL Sale (or disposition) back to the issuer	$45,000 $90.0 p/Share	500 Reduced 0.33%	152,950 Common Stock

Dec 19 2025	BUY Grant, award, or other acquisition	-	518 Added 0.34%	153,468 Common Stock
Dec 19 2025	BUY Grant, award, or other acquisition	$18,690 $37.38 p/Share	500 Added 0.32%	153,450 Common Stock
Dec 18 2025	SELL Sale (or disposition) back to the issuer	$755,674 $90.09 p/Share	8,388 Reduced 5.2%	152,950 Common Stock
Dec 18 2025	BUY Grant, award, or other acquisition	$313,543 $37.38 p/Share	8,388 Added 4.94%	161,338 Common Stock
Sep 26 2025	BUY Grant, award, or other acquisition	-	545 Added 0.36%	152,950 Common Stock
Jun 27 2025	BUY Grant, award, or other acquisition	-	549 Added 0.36%	152,405 Common Stock
Mar 28 2025	BUY Grant, award, or other acquisition	-	512 Added 0.34%	151,856 Common Stock
Feb 28 2025	SELL Payment of exercise price or tax liability	$408,248 $89.04 p/Share	4,585 Reduced 2.94%	151,344 Common Stock
Feb 24 2025	BUY Grant, award, or other acquisition	-	43,573 Added 21.84%	155,929 Common Stock
Jan 15 2025	SELL Sale (or disposition) back to the issuer	$1,753,290 $80.5 p/Share	21,780 Reduced 16.24%	112,356 Common Stock
Jan 15 2025	BUY Grant, award, or other acquisition	$1,117,967 $51.33 p/Share	21,780 Added 13.97%	134,136 Common Stock
Dec 18 2024	BUY Grant, award, or other acquisition	-	360 Added 0.32%	112,356 Common Stock
Sep 27 2024	BUY Grant, award, or other acquisition	-	307 Added 0.27%	111,996 Common Stock
Jun 28 2024	BUY Grant, award, or other acquisition	-	325 Added 0.29%	111,689 Common Stock
Mar 28 2024	BUY Grant, award, or other acquisition	-	288 Added 0.26%	111,364 Common Stock
Feb 26 2024	BUY Grant, award, or other acquisition	-	26,147 Added 19.05%	111,076 Common Stock
Dec 20 2023	BUY Grant, award, or other acquisition	-	184 Added 0.22%	84,929 Common Stock
Sep 29 2023	BUY Grant, award, or other acquisition	-	193 Added 0.23%	84,745 Common Stock

Also insider at

ELV

Elevance Health, Inc. Healthcare

Director

DDS